About BioTwin
BioTwin is a Real Estate & Construction company based in London (United Kingdom) founded in 2023 by Kit Chong and Matthew Elton. Carbon construction materials are manufactured for the building sector. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. BioTwin has raised $212.47 thousand across 1 funding round from investors including SFC Capital. The company has 3 employees. Its chief executive, as recorded, is Kit Chong. BioTwin offers products and services including BioStuds. Its focus areas include Construction, Building Materials and Sustainable Materials. Its legal entity is BioTwin Limited.
Company details
Hemp-based wall studs, known as BioStuds, are produced by BioTwin for non-load bearing partition walls in the construction sector. These studs are designed as a sustainable alternative to steel, offering a 71.5 lower carbon footprint, proven fire resistance, and superior acoustic performance. Solutions are tailored for developers, contractors, architects, and distributors, supporting compliance with carbon regulations and alignment with Net Zero goals. Compatibility with existing building systems is ensured, facilitating easy adoption in modern construction projects.
- Headquarters London, United Kingdom
- Employees 3
- Founders Kit Chong, Matthew Elton
- SectorsReal Estate & Construction
- Website biotwin.co.uk
- Social LinkedIn Instagram
- Legal Name Biotwin Limited
- Total Equity Funding$212.47K (USD)
in 1 rounds
- Latest Funding Round$212.47K (USD), Seed
Oct 2023
- Investors
- Employee Count3
Products & Services of BioTwin
BioTwin offers a comprehensive portfolio of products and services, including BioStuds.
Hemp-based studs are used for partition walls.
Funding Insights of BioTwin
BioTwin has successfully raised a total of $212.47K through 1 strategic funding round. The most recent funding activity was a Seed round of $212.47 thousand completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $212,473
- Total Rounds 1
- Last Round Seed — $212,473
- First Round $212,473
(Oct 2023)
- Investors Count 1
All 1 funding rounds of BioTwin with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $212,473 | Seed | – | SFC Capital | – |
1 investors in total: 1 institutional.
Investors in BioTwin
BioTwin has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SFC Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Introductions between investors and early-stage companies are facilitated for funding. | sfccapital.com | Northwich, United Kingdom |
Investor details for BioTwin
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioTwin
2 people are tracked at BioTwin (2 in leadership); the tracked headcount is 3.
| Name | Role | Group |
|---|---|---|
Kit Chong | Co-Founder & CEO | Leadership |
Matthew Elton | Co-Founder | Leadership |
Complete people profiles for BioTwin
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioTwin
2 dated milestones of BioTwin, from founding to its latest funding, stage changes and deals.
- Founded BioTwin is founded.
- Funding First funding round of $212K.
Web traffic of BioTwin
The website of BioTwin (biotwin.co.uk) receives about 1.1K visits a month.
- Monthly visits1.1K
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioTwin
BioTwin was founded in 2023.
BioTwin is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Kit Chong is the CEO of BioTwin, as recorded in our data. They have also founded this company.
BioTwin is a funded company, having raised a total of $212.47K across 1 funding round to date. The company's 1st funding round was a Seed of $212.47K, raised on Oct 2023.
BioTwin has 3 employees.
Hemp-based wall studs, known as BioStuds, are produced by BioTwin for non-load bearing partition walls in the construction sector. These studs are designed as a sustainable alternative to steel, offering a 71.5 lower carbon footprint, proven fire resistance, and superior acoustic performance. Solutions are tailored for developers, contractors, architects, and distributors, supporting compliance with carbon regulations and alignment with Net Zero goals. Compatibility with existing building systems is ensured, facilitating easy adoption in modern construction projects.
BioTwin offers BioStuds.
BioTwin has 1 investor. Key investors include SFC Capital.
BioTwin operates through Biotwin Limited.